We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Lloyd Friedman

Lloyd Friedman MD

Clinical Professor of Medicine (Pulmonology), Yale School of Medicine, Yale University, New Haven, CT
Lloyd Friedman, MD, is a pulmonary critical care specialist who primarily treats tuberculosis, latent tuberculosis infection and nontuberculous mycobacteria. He also cares for critically ill patients in the intensive care unit at Yale New Haven Hospital.

A clinical professor of medicine (pulmonology), Dr. Friedman has been at Yale since 1989. The major focus of his research is an experimental project concerning the association of tuberculosis and asthma. He recently published the results of a multicenter trial investigating the incidence of reversion of latent tuberculosis infection through the use of skin tests and interferon gamma release assays.